Sharon Rosenzweig Lipson from Life Biosciences at ARDD2023: Epigenetic reprogramming- A novel gene..

Sharon Rosenzweig-Lipson , Life Biosciences, USA presents at the 10th Aging Research and Drug Discovery conference: Epigenetic reprogramming- A novel gene therapy that restores visual function in a nonhuman primate model of NAION

[@fourthrockonearth]

Os it just me or did she describe a great leap forward to cure blindness...

[@houndofzoltan]

She seemed very nervous, but she did a great job. Very interesting talk.

[@Simone-lb8zr]

The research is absolutely stunning and many people are pending from any news regarding this study. However, I think the difference between targeting "degenerating" or "dead" retina cells in the end of the talk, could have worth a bit more time explanation. Also, do you plan a glaucoma model for the non-human primate test?